Miroslav L Djordjevic1,2,3, Marko Bencic4,5, Vladimir Kojovic4,6, Borko Stojanovic4,5, Marta Bizic4,5,6, Sinisa Kojic4, Zoran Krstic4,6, Gradimir Korac4,5. 1. Belgrade Center for Genital Reconstructive Surgery, Belgrade, Serbia. djordjevic@uromiros.com. 2. University Children's Hospital, Belgrade, Serbia. djordjevic@uromiros.com. 3. School of Medicine, University of Belgrade, Belgrade, Serbia. djordjevic@uromiros.com. 4. Belgrade Center for Genital Reconstructive Surgery, Belgrade, Serbia. 5. University Children's Hospital, Belgrade, Serbia. 6. School of Medicine, University of Belgrade, Belgrade, Serbia.
Abstract
PURPOSE: Despite a variety of free flaps that have been described for creation of the neophallus in gender affirmation surgery, none present an ideal solution. We evaluated our patients and outcomes after gender affirmation phalloplasty using musculocutaneous latissimus dorsi free flap. METHODS: Between January 2007 and May 2017, 129 female transsexuals, aged 20-53 years (mean 24 years) underwent total phalloplasty using latissimus dorsi free flap. Urethral lengthening was performed by combining a vaginal flap, labia minora flaps and a clitoral skin flap. Suitable sized testicular implants are inserted into the new scrotum. Penile prosthesis implantation, additional urethral lengthening and glans reshaping were performed in the following stages. RESULTS: The mean follow-up period was 43 months (ranged from 13 to 137 months). There were one partial and two total flap necrosis. The average size of the neophallus was 14.6 cm in length and 12.4 cm in girth. Total length of the reconstructed urethra during the first stage ranged from 13.4 to 21.7 cm (mean 15.8 cm), reaching the proximal third or the midshaft of the neophallus in 91% of cases. Satisfactory voiding in standing position was confirmed in all patients. Six urethral fistulas and two strictures were observed and repaired by minor revision. Malleable and inflatable prostheses were implanted in 39 and 22 patients, respectively. CONCLUSION: Musculocutaneous latissimus dorsi flap is a good choice for phalloplasty in gender affirmation surgery. It provides an adequate amount of tissue with sufficient blood supply for safe urethral reconstruction and penile prosthesis implantation.
PURPOSE: Despite a variety of free flaps that have been described for creation of the neophallus in gender affirmation surgery, none present an ideal solution. We evaluated our patients and outcomes after gender affirmation phalloplasty using musculocutaneous latissimus dorsi free flap. METHODS: Between January 2007 and May 2017, 129 female transsexuals, aged 20-53 years (mean 24 years) underwent total phalloplasty using latissimus dorsi free flap. Urethral lengthening was performed by combining a vaginal flap, labia minora flaps and a clitoral skin flap. Suitable sized testicular implants are inserted into the new scrotum. Penile prosthesis implantation, additional urethral lengthening and glans reshaping were performed in the following stages. RESULTS: The mean follow-up period was 43 months (ranged from 13 to 137 months). There were one partial and two total flap necrosis. The average size of the neophallus was 14.6 cm in length and 12.4 cm in girth. Total length of the reconstructed urethra during the first stage ranged from 13.4 to 21.7 cm (mean 15.8 cm), reaching the proximal third or the midshaft of the neophallus in 91% of cases. Satisfactory voiding in standing position was confirmed in all patients. Six urethral fistulas and two strictures were observed and repaired by minor revision. Malleable and inflatable prostheses were implanted in 39 and 22 patients, respectively. CONCLUSION: Musculocutaneous latissimus dorsi flap is a good choice for phalloplasty in gender affirmation surgery. It provides an adequate amount of tissue with sufficient blood supply for safe urethral reconstruction and penile prosthesis implantation.
Entities:
Keywords:
Female to male transgender; Gender affirmation surgery; Latissimus dorsi; Phalloplasty; Urethroplasty
Authors: Tatjana B Bubanj; Sava V Perovic; Ruzica M Milicevic; Stevan B Jovcic; Zoran O Marjanovic; Miroslav M Djordjevic Journal: J Urol Date: 2004-05 Impact factor: 7.450
Authors: Miroslav L Djordjevic; Marko Z Bumbasirevic; Zoran Krstic; Marta R Bizic; Borko Z Stojanovic; Ranko Miocinovic; Richard A Santucci Journal: Urology Date: 2013-11-22 Impact factor: 2.649
Authors: Daniel Boczar; Maria T Huayllani; Humza Y Saleem; Gabriela Cinotto; Francisco R Avila; Salam Kassis; Xiaona Lu; Brian D Rinker; Antonio J Forte Journal: Ann Transl Med Date: 2021-04